Trials / Completed
CompletedNCT06338202
Real-World Effectiveness of Mavacamten in Canada
Real-World Effectiveness of MAVacamtEN in Canada (MAVEN): A Retrospective Physician Survey of Patient Charts
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this observational, retrospective, physician survey study is to describe the real-world effectiveness and use of mavacamten in participants who initiated treatment for obstructive hypertrophic cardiomyopathy (oHCM) in Canada.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mavacamten | As detailed in the product label |
Timeline
- Start date
- 2024-06-24
- Primary completion
- 2024-11-12
- Completion
- 2024-12-19
- First posted
- 2024-03-29
- Last updated
- 2025-12-04
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06338202. Inclusion in this directory is not an endorsement.